I didn’t read the entire article and i am not a physician.
That said, your point #2 sounds incorrect - aspartame doesn’t cause atherosclerosis, it aggravates atherosclerosis. The key difference there as it relates to type 2 diabetes patients is that presumably if they had atherosclerosis as an existing condition, they would qualify for a glp-1 with cvd benefits, and not be on sulfonylureas in the first place.
That said, your point #2 sounds incorrect - aspartame doesn’t cause atherosclerosis, it aggravates atherosclerosis. The key difference there as it relates to type 2 diabetes patients is that presumably if they had atherosclerosis as an existing condition, they would qualify for a glp-1 with cvd benefits, and not be on sulfonylureas in the first place.